Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diffuse panbronchiolitis: role of macrolides in therapy.

Naoto Keicho1, Shoji Kudoh

  • 1Department of Respiratory Diseases, Research Institute, International Medical Center of Japan,Toyama, Shinjuku-ku, Tokyo, Japan.

American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions
|January 15, 2004
PubMed
Summary

Low-dose, long-term macrolide antibiotics significantly improve prognosis for diffuse panbronchiolitis (DPB). Their anti-inflammatory effects, not bacterial killing, are key to treating this chronic sinobronchial infection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigation of factors affecting the accuracy of portable monitors in Japanese professional drivers with suspected obstructive sleep apnea.

Respiratory investigation·2026
Same author

Genome-guided pooled infection and whole-genome sequencing identify clinical Mycobacterium avium complex isolates that persist in a murine infection model.

Journal of microbiological methods·2026
Same author

Epidemiology and clinical characteristics of primary ciliary dyskinesia in Japan: A nationwide database analysis.

Respiratory investigation·2026
Same author

Strain-dependent disease progression and necrotizing granuloma formation in a murine model induced by virulent strains of <i>Mycobacterium avium</i> complex.

Microbiology spectrum·2026
Same author

<i>Mafb</i> deficiency in myeloid cells increases susceptibility to <i>Mycobacterium tuberculosis</i> infection in mice.

Frontiers in immunology·2026
Same author

Clinical characteristics and severity of primary ciliary dyskinesia caused by large homozygous deletion including exons 1-4 of DRC1: A multicenter retrospective cohort study.

Respiratory investigation·2026

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Pharmacology

Background:

  • Diffuse panbronchiolitis (DPB) is a chronic sinobronchial inflammatory disease with a genetic predisposition in Asian populations.
  • Historically, DPB treatment was primarily symptomatic, with limited efficacy.
  • The introduction of macrolide antibiotics revolutionized DPB management and prognosis.

Purpose of the Study:

  • To investigate the efficacy and underlying mechanisms of low-dose, long-term macrolide therapy in diffuse panbronchiolitis.
  • To explore the non-bactericidal anti-inflammatory actions of macrolides in DPB.
  • To assess the potential of macrolide therapy for other chronic inflammatory conditions.

Main Methods:

  • Retrospective analysis of clinical outcomes in DPB patients treated with macrolides.

Related Experiment Videos

  • In vitro and in vivo studies examining macrolide effects on inflammatory mediators and bacterial virulence.
  • Pharmacokinetic studies to determine macrolide tissue concentrations relative to Minimum Inhibitory Concentrations (MICs).

    • Main Results:

    • Macrolide therapy, particularly erythromycin, leads to significant clinical improvement in DPB, independent of bacterial clearance.
    • Efficacy is observed even in cases with macrolide-resistant Pseudomonas aeruginosa infections.
    • Macrolide dosages used achieve sub-MIC levels in tissues, suggesting a primary anti-inflammatory role.

    Conclusions:

    • Low-dose, long-term macrolide therapy is a highly effective treatment for diffuse panbronchiolitis, primarily through anti-inflammatory mechanisms.
    • Macrolides reduce airway inflammation by inhibiting neutrophil and lymphocyte accumulation and modulating mucus secretion.
    • The anti-inflammatory properties of macrolides warrant further investigation for treating other chronic inflammatory diseases, potentially leading to development of non-antimicrobial macrolide agents.